Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palivizumab for prevention of RSV-associated wheeze in preterm infants
NL-OMON47056Recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Aug 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Randomised trial in respiratory syncytial virus disease (RSV), bronchiolitis and pulmonary infection comparing Palivizumab with Placebo (2 arms). Primary endpoints: Number of wheezing days during the first year of life, Asthma and allergy status at age 6 years and 1 more. Started Aug 2008; status: recruiting.
02
Drugs
palivizumab
03
Conditions
respiratory syncytial virus disease (RSV)bronchiolitispulmonary infection
Beyond the preview
Go deeper on NL-OMON47056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47056.